by Clinical Neuropsychologist Online | Sunday, July 19, 2026 | Dementia
Abstract INTRODUCTION Neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), limbic-predominant age-related TDP-43 encephalopathy (LATE), and Alzheimer’s disease (AD) are associated with TAR DNA-binding protein...
by Clinical Neuropsychologist Online | Sunday, July 19, 2026 | Dementia
Abstract INTRODUCTION The National Institute on Aging-funded IMbedded Pragmatic Alzheimer’s disease and AD-Related Dementias Clinical Trials (IMPACT) Collaboratory was established to build capacity for conducting embedded pragmatic clinical trials (ePCTs) within...
by Clinical Neuropsychologist Online | Thursday, July 16, 2026 | Dementia
Alzheimer’s &Dementia, Volume 22, Issue 7, July 2026. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | July 16, 2026 Neuro-Dementia Previous...
by Clinical Neuropsychologist Online | Wednesday, July 15, 2026 | Dementia
Abstract INTRODUCTION Lewy body (LB) co-pathology is common in Alzheimer’s disease (AD), yet its in vivo impact on neurodegeneration remains unclear. METHODS We trained a 3D-DenseNet on multi-cohort T1-weighted magnetic resonance imaging (MRI) from cognitively...
by Clinical Neuropsychologist Online | Wednesday, July 15, 2026 | Dementia
Abstract BACKGROUND Patients with sporadic frontotemporal dementia (FTD) display changes in metabolism and body composition. No studies have examined body composition changes in pre-symptomatic C9orf72 mutation carriers METHODS Asymptomatic C9orf72 expansion carriers...
